Department of Radiology, Selcuklu Medical Faculty, Selcuk University, Konya, Turkey.
J Investig Med. 2011 Oct;59(7):1137-40. doi: 10.2310/JIM.0b013e31822a29f5.
A relationship between liver diseases and serum vitamin B12 levels was observed in previous reports. The purpose of this study was to determine if a similar relationship existed between vitamin B12 and nonalcoholic fatty liver disease (NAFLD), a common chronic liver disorder.
A total of 45 consecutive patients with NAFLD formed the NAFLD group, whereas 30 healthy controls (HC) formed the HC group. The subjects in all of the groups were of similar age and body mass index (BMI). A fatty liver is described in 3 ultrasonographic grades. Fasting blood samples were obtained, and serum vitamin B12 levels were measured. In addition, liver enzymes including aspartate aminotransferase, alanine aminotransferase (ALT), and alkaline phosphatase, and folic acid and other serum parameters were evaluated. The Mann-Whitney U test, χ2 test, and Spearman correlation analysis were used to compare the vitamin B12 levels and other serum parameters in both groups.
The mean ± SD age and BMI of the NAFLD were 47.2 ± 11.2 and 28.8 ± 3.5. The mean ± SD age and BMI of the HC were 47.1 ± 8.8 and 27.7 ± 2.9, respectively. The serum aspartate aminotransferase and ALT levels of the patients with NAFLD were statistically higher compared with those of the controls (P = 0.001). The levels of vitamin B12 and folate were statistically lower in the NAFLD patients compared with those of the controls (P < 0.05). We found that there was a reduction of vitamin B12 levels, especially in grade 2 to grade 3 hepatosteatosis. In addition, in the Spearman correlation analysis between the vitamin B12 levels and ALT, the grade of fatty liver and the liver dimension were found to have an important negative correlation.
The serum vitamin B12 levels were significantly lower in the patients with NAFLD than in those of the control group; however, these still remain in the reference range. Consequently, low vitamin B12 levels may be associated with NAFLD especially in grade 2 to grade 3 hepatosteatosis.
先前的报告表明肝脏疾病与血清维生素 B12 水平之间存在关联。本研究旨在确定维生素 B12 与非酒精性脂肪性肝病(NAFLD)之间是否存在类似的关系,NAFLD 是一种常见的慢性肝病。
45 例连续的 NAFLD 患者组成 NAFLD 组,30 例健康对照者(HC)组成 HC 组。所有组的受试者年龄和体重指数(BMI)相似。肝脏超声检查显示存在 3 个脂肪性肝病超声严重程度等级。采集空腹血样并测量血清维生素 B12 水平。同时评估包括天冬氨酸氨基转移酶、丙氨酸氨基转移酶(ALT)和碱性磷酸酶在内的肝酶以及叶酸和其他血清参数。采用 Mann-Whitney U 检验、χ2 检验和 Spearman 相关分析比较两组的维生素 B12 水平和其他血清参数。
NAFLD 组的平均年龄±标准差为 47.2±11.2 岁,BMI 为 28.8±3.5。HC 组的平均年龄±标准差为 47.1±8.8 岁,BMI 为 27.7±2.9。NAFLD 患者的血清天冬氨酸氨基转移酶和 ALT 水平明显高于对照组(P=0.001)。NAFLD 患者的维生素 B12 和叶酸水平明显低于对照组(P<0.05)。我们发现维生素 B12 水平降低,尤其是在 2 级至 3 级肝脂肪变性中。此外,在维生素 B12 水平与 ALT、脂肪肝程度和肝尺寸之间的 Spearman 相关分析中,发现两者之间存在重要的负相关。
NAFLD 患者的血清维生素 B12 水平明显低于对照组,但仍处于参考范围。因此,低维生素 B12 水平可能与 NAFLD 相关,尤其是在 2 级至 3 级肝脂肪变性中。